Stockscreener 앱 받기
43.16
3.68%
1.53
시장 영업 전:
43.48
0.32
+0.74%
Sanofi Adr 주식(SNY)의 최신 뉴스
Communiqué de presse : Mise en ligne du document «Q2 2026 aide-mémoire » - GlobeNewswire Inc.
Sanofi stock slides as price lingers below the long-term average - Traders Union
9 New 5-Star Stocks This Week - Morningstar
SNW2 Forecast — Price Target — Prediction for 2027 - TradingView
662283 Forecast — Price Target — Prediction for 2027 - TradingView
EU Launches Antitrust Probe Into Sanofi Over Allegedly Misleading Flu Vaccine Claims - Sahm
Sanofi faces EU probe, shares steady after Friday’s Reuters report - AD HOC NEWS
Sanofi SA Sponsored ADR Actuals & Estimates (NASDAQ:SNY) - TradingView
Enterprise value to revenue forward of Sanofi SA Sponsored ADR – LSE:0A2V - TradingView
Price to earnings forward of Sanofi SA Sponsored ADR – LSE:0A2V - TradingView
Price to book forward of Sanofi SA Sponsored ADR – LSE:0A2V - TradingView
Europe Approves Sanofi's Multiple Sclerosis Drug Despite FDA Rejection - Sahm
Sanofi analyst focus on Dupixent and pipeline, shares tracked against Big Pharma peers - AD HOC NEWS
Muted Sanofi hits fresh 52-week low, shares trade well below analyst targets - AD HOC NEWS
Form 6K Sanofi ADR For: 22 June By Investing.com - Investing.com Australia
Sanofi-ADR (NASDAQ:SNY): A High-Yield Dividend Stock with Strong Fundamentals - ChartMill
Sanofi S.A. Stock (FR0000127771): Deutsche Bank trims target but sticks with Buy - Ad-hoc-news.de
FDA OKs Sanofi Diabetes Drug In Newly Diagnosed Pediatric Patients - Sahm
Sanofi S.A. Stock (FR0000120578): FDA accelerated approval for Tzield puts diabetes franchise in foc - AD HOC NEWS
Sanofi S.A. Stock (FR0000120578): Valuation Metrics Under the Microscope - Ad-hoc-news.de
Sanofi S.A. Stock (FR0000127771): Stock in focus as no fresh trigger is verified - Ad-hoc-news.de
Sanofi Trial Setback May Reinforce Argenx Vyvgart's Position In CIDP, Analyst Says - Sahm
Sanofi S.A. stock (FR0000127771): Diabetes focus and pipeline news keep Big Pharma in motion - Ad-hoc-news.de
European ADRs Started The Week In The Green - Finimize
Sanofi S.A. stock (FR0000127771): diabetes deal and pipeline focus move into the spotlight - AD HOC NEWS
Sanofi-Owkin Expand AI Collaboration With New Agentic AI Initiative - Sahm
Senior Chinese legislator meets Myanmar's foreign minister - news.cgtn.com
Sanofi (SASY) Stock: Pharma Giant Launches AI Sales Agent Built on Snowflake - MEXC
SNY Stock Price, Quote & Chart | SANOFI-ADR (NASDAQ:SNY) - ChartMill
Sanofi S.A. stock (FR0000120578): analyst consensus steady as ADRs trade in low-40s USD range - AD HOC NEWS
Sanofi S.A. stock (FR0000127771): Analyst consensus points to hold stance as shares hover in low-40s - AD HOC NEWS
Sanofi S.A. stock (FR0000127771): Technical picture and price action on Euronext Paris - AD HOC NEWS
Sanofi S.A. stock (FR0000120578): Vaccine and obesity focus after Q1 2026 earnings - AD HOC NEWS
SNYSanofi ADR Stock Price and Quote - Finviz
Sanofi S.A. stock (FR0000120578): Q1 results, pipeline focus and outlook for US investors - AD HOC NEWS
SANOFI-ADR (NASDAQ:SNY): A Quality Dividend Stock with a 5.31% Yield and Strong Fundamentals - ChartMill
Publicis Groupe stock (FR0000120578): LiveRamp deal and AI push keep investors focused - AD HOC NEWS
Publicis Groupe S.A. stock (FR0000120578): LiveRamp deal and AI push reshape data strategy - AD HOC NEWS
Sanofi S.A. stock (FR0000127771): EU green light for multiple myeloma drug Sarclisa draws investor f - AD HOC NEWS
Sanofi S.A. stock (FR0000127771): Vaccine unit and new drug launches keep investors alert - AD HOC NEWS
Sanofi S.A. stock (FR0000120578): Q1 beat and pipeline focus keep investors watching - Ad-hoc-news.de
Sanofi stock (FR0000120578): Pipeline updates keep investors watching - Ad-hoc-news.de
Sanofi stock (FR0000120578): trial data and EU approval updates - AD HOC NEWS
Sanofi stock (FR0000120578): Dupixent data and AI investment keep focus on growth - AD HOC NEWS
Sanofi stock (FR0000120578): FDA, dividend and Dupixent keep investors focused - AD HOC NEWS
1.84%
자본화:
|
볼륨(24시간):